"Emtricitabine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A deoxycytidine analog and REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B viruses. It is used to treat HIV INFECTIONS.
| Descriptor ID |
D000068679
|
| MeSH Number(s) |
D03.383.742.680.245.500.600 D13.570.230.329.525 D13.570.685.245.500.600
|
| Concept/Terms |
Emtricitabine- Emtricitabine
- Beta-L-2',3'-dideoxy-5-fluoro-3'-thiacytidine
- Beta L 2',3' dideoxy 5 fluoro 3' thiacytidine
|
Below are MeSH descriptors whose meaning is more general than "Emtricitabine".
Below are MeSH descriptors whose meaning is more specific than "Emtricitabine".
This graph shows the total number of publications written about "Emtricitabine" by people in this website by year, and whether "Emtricitabine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 2 | 2 |
| 2025 | 0 | 1 | 1 |
| 2026 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Emtricitabine" by people in Profiles.
-
The safety and tolerability of oral TDF/FTC as pre-exposure prophylaxis among men who have sex with men in China: a prospective cohort study. BMC Infect Dis. 2026 May 21; 26(1).
-
Daily PrEP and event-driven PrEP adherence for men who have sex with men in China. Sex Health. 2026 02 05; 23(1).
-
HIV pre-exposure prophylaxis re-initiation among men who have sex with men: a multi-center cohort study in China. Sex Health. 2025 03; 22.
-
Patterns of daily oral HIV PrEP adherence among people who inject drugs in Ukraine: an analysis of biomarkers. J Int AIDS Soc. 2024 Jul; 27 Suppl 3:e26319.
-
Acute facial neuralgia related to initiation of emtricitabine/tenofovir for HIV PrEP: a report of two cases in a PrEP demonstration trial. Sex Health. 2024 01; 21.
-
Low daily oral PrEP adherence and low validity of self-report in a randomized trial among PWID in Ukraine. Int J Drug Policy. 2024 01; 123:104284.
-
Same-day prescribing of daily oral pre-exposure prophylaxis for HIV prevention. Lancet HIV. 2021 02; 8(2):e114-e120.
-
Loss of Virologic Control and Severe Pneumocystis pneumonia in an HIV-Infected Patient Receiving Chemotherapy for Non-Small Cell Lung Cancer. AIDS Res Hum Retroviruses. 2016 Jan; 32(1):4-5.